Help us: Donate
Follow us on:
×

SENS Research Foundation Announces Ending Aging Forum 2022

Sept 2 - Sept 3 9:00 am to 2:30 pm PDT

Ending AgingEnding Aging
 

SENS Research Foundation has announced this year’s Ending Aging Forum, which will be held through a virtual conference platform with an immersive environment.

Come spend a wonderful and thought provoking time with the team at SENS Research Foundation. This virtual event is your opportunity to hear first-hand about the latest advances that our in-house researchers are making toward new rejuvenation biotechnologies, along with some of our young scientists-in-training and outside researchers whose research we fund. In addition to the formal presentations, you’ll have the opportunity to talk one-on-one with the scientists and other members of our team, as well as with citizens, donors, and activists who dream of and work for a future free of degenerative aging.

Breaking down the barriers to attendance, the Forum will be hosted virtually through EXVO, a strong platform for this VR experience. Registered attendees will receive instructions on how to join the conversation shortly before the event begins. The virtual event will have a Conference Hall, where feature presentations are made, along with project-specific Research Booths and booths for scientific posters presented by our students that break down different research projects. In the Expo Room, attendees can also meet and talk one-on-one or in small groups with the team and other supporters, or watch videos in which our team members and scientists-in-training introduce themselves and what drew them to this Mission. The platform dispenses with the tedium of navigating your avatar around the event space and also giving you the power to ‘teleport’ from one virtual location to another. Join us to learn and celebrate how far we’ve come, and to catch a glimpse of the future we’re building!

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Longevity Investors Lunch at Davos

A Longevity Investors Lunch hosted by Maximon, Longevity Investors Conference, and Biolytica has been hosted at a satellite event of...

Open Longevity Foundation Announces Open Genes Database

Open Longevity Foundation has announced Open Genes, a database of longevity-associated genes and a tool for future anti-aging therapy development....

Gero Enters Research Collaboration with Pfizer

Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform...

Immunis Begins Clinical Trial of Stem Cell Secretome

Intending to treat sarcopenia, the private biotechnology company Immunis has begun a human clinical trial of a stem cell secretome...

No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.